Lista de obras - Gerard Morton - Dominio Público Uruguay

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy

scientific article published on 01 June 2002

A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost

artículo científico publicado en 2014

A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.

artículo científico publicado en 2007

A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019

artículo científico publicado en 2006

A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019

artículo científico publicado en 2005

Accelerated hypofractioned postoperative radiotherapy for prostate cancer: a prospective phase I/II study

artículo científico publicado en 2015

American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy.

artículo científico

Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using national cancer institute expanded common toxicity criteria

artículo científico publicado en 2008

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam B

artículo científico publicado en 2016

Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?

artículo científico publicado en 2003

Brachytherapy: current status and future strategies -- can high dose rate replace low dose rate and external beam radiotherapy?

artículo científico

Canadian prostate brachytherapy in 2012.

artículo científico

Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma

artículo científico publicado en 2006

Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists

scientific article published on 01 October 2003

Delivery of brachytherapy for cervical cancer: organisational and technical advice to facilitate high-quality care.

artículo científico publicado en 2010

Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study).

artículo científico publicado en 2016

Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program

artículo científico publicado en 2016

Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery.

artículo científico publicado en 2005

Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy

artículo científico publicado en 2006

Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.

artículo científico publicado en 2009

Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.

artículo científico publicado en 2016

Fulminant hepatic failure associated with bicalutamide

scientific article published on 01 February 1997

Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer

artículo científico publicado en 2010

High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success

artículo científico publicado en 2015

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique

artículo científico publicado en 2014

How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?

scientific article published on 01 November 2007

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results

scientific article published on 20 March 2008

Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity

artículo científico publicado en 2011

Imaging technologies for high dose rate brachytherapy for cervical cancer: a systematic review.

artículo científico publicado en 2011

Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer

artículo científico publicado en 2005

Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging

artículo científico publicado en 2012

Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.

artículo científico publicado en 2016

Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

artículo científico publicado en 2011

Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019

scientific article published on 01 April 2007

Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery

artículo científico publicado en 2004

Long-Term Results of a Phase II Trial of Ultrasound-Guided Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate (RTOG 98-05) ⬇️

artículo científico publicado el 4 de abril de 2011

Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer.

artículo científico publicado en 2017

Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma

artículo científico publicado en 2005

Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer.

artículo científico publicado en 2015

Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia.

artículo científico publicado en 2006

MR-guided prostate biopsy for planning of focal salvage after radiation therapy

artículo científico publicado en 2014

Megavoltage cone beam digital tomosynthesis (MV-CBDT) for image-guided radiotherapy: a clinical investigational system

artículo científico publicado en 2008

PSA doubling time of prostate carcinoma managed with watchful observation alone

artículo científico publicado en 2001

Pathological predictors for site of local recurrence after radiotherapy for prostate cancer.

artículo científico publicado en 2012

Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.

artículo científico publicado en 2008

Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?

artículo científico publicado en 2002

Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial

artículo científico publicado en 2013

Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy.

artículo científico publicado en 2008

Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy

artículo científico publicado en 2006

Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.

artículo científico publicado en 2009

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy

artículo científico publicado en 2016

Prostate high-dose-rate brachytherapy: Transrectal ultrasound based planning, a technical note

scientific article published on 18 February 2015

Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol

artículo científico publicado en 2006

Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer

artículo científico publicado en 2011

Quantitative ultrasound spectroscopic imaging for characterization of disease extent in prostate cancer patients

artículo científico publicado en 2015

Radiation treatment of bladder squamous cell carcinoma in a patient with spina bifida: A case report ⬇️

artículo científico publicado el 1 de junio de 2012

Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05)

scientific article published on 02 November 2006

Role of radiotherapy in the treatment of cancer of the ovary.

artículo científico publicado en 1994

Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.

artículo científico publicado en 2016

Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectiveness

artículo científico publicado en 2014

Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life

artículo científico publicado en 2009

Target position variability throughout prostate radiotherapy

artículo científico publicado en 1998

Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.

artículo científico publicado en 2008

The best method for dose escalation: Prostate brachytherapy

artículo científico publicado en 2012

The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer

artículo científico publicado en 2014

The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer

article

The role of serial free/total prostate-specific antigen ratios in a watchful observation protocol for men with localized prostate cancer.

artículo científico publicado en 2002

The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer

artículo científico publicado en 2001

Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma.

artículo científico publicado en 2002

Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy

scientific article published on 28 December 2010

Wide variation of prostate-specific antigen doubling time of untreated, clinically localized, low-to-intermediate grade, prostate carcinoma

artículo científico publicado en 2004

Lista de obras de Gerard Morton

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy

A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost

A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.

A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019

A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019

Accelerated hypofractioned postoperative radiotherapy for prostate cancer: a prospective phase I/II study

American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy.

Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using national cancer institute expanded common toxicity criteria

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam B

Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?

Brachytherapy: current status and future strategies -- can high dose rate replace low dose rate and external beam radiotherapy?

Canadian prostate brachytherapy in 2012.

Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma

Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists

Delivery of brachytherapy for cervical cancer: organisational and technical advice to facilitate high-quality care.

Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study).

Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program

Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery.

Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy

Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.

Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.

Fulminant hepatic failure associated with bicalutamide

Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer

High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique

How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results

Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity

Imaging technologies for high dose rate brachytherapy for cervical cancer: a systematic review.

Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer

Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging

Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.

Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019

Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery

Long-Term Results of a Phase II Trial of Ultrasound-Guided Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate (RTOG 98-05) ⬇️

Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer.

Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma

Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer.

Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia.

MR-guided prostate biopsy for planning of focal salvage after radiation therapy

Megavoltage cone beam digital tomosynthesis (MV-CBDT) for image-guided radiotherapy: a clinical investigational system

PSA doubling time of prostate carcinoma managed with watchful observation alone

Pathological predictors for site of local recurrence after radiotherapy for prostate cancer.

Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.

Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?

Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial

Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy.

Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy

Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy

Prostate high-dose-rate brachytherapy: Transrectal ultrasound based planning, a technical note

Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol

Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer

Quantitative ultrasound spectroscopic imaging for characterization of disease extent in prostate cancer patients

Radiation treatment of bladder squamous cell carcinoma in a patient with spina bifida: A case report ⬇️

Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05)

Role of radiotherapy in the treatment of cancer of the ovary.

Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.

Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectiveness

Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life

Target position variability throughout prostate radiotherapy

Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.

The best method for dose escalation: Prostate brachytherapy

The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer

The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer

The role of serial free/total prostate-specific antigen ratios in a watchful observation protocol for men with localized prostate cancer.

The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer

Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma.

Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy

Wide variation of prostate-specific antigen doubling time of untreated, clinically localized, low-to-intermediate grade, prostate carcinoma